Skip to main content
Book cover

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

  • Book
  • © 2012

Overview

  • Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients
  • Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)
  • Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers
  • Includes supplementary material: sn.pub/extras

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 195)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (22 chapters)

  1. Introduction

  2. Minimal Residual Disease and Breast Cancer Metastasis

  3. Minimal residual disease and breast cancer metastasis

  4. Technologies for Circulating Tumor Cell and Disseminated Tumor Cell Detection and Characterization

  5. Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization

  6. Other Blood-Based Biomarkers

  7. Other blood-based biomarkers

  8. Disseminated Tumor Cells and Circulating Tumor Cells in Breast Cancer Clinical Research and Practice

Keywords

About this book

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

Editors and Affiliations

  • , Breast Cancer Translational Res. Lab., Institut Jules Bordet, Brussels, Belgium

    Michail Ignatiadis, Christos Sotiriou

  • Zentrum für Experimentelle Medizin, Inst. Tumorbiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

    Klaus Pantel

Bibliographic Information

  • Book Title: Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

  • Editors: Michail Ignatiadis, Christos Sotiriou, Klaus Pantel

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-28160-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2012

  • Hardcover ISBN: 978-3-642-28159-4Published: 23 April 2012

  • Softcover ISBN: 978-3-642-44587-3Published: 09 May 2014

  • eBook ISBN: 978-3-642-28160-0Published: 23 April 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XIV, 254

  • Topics: Oncology, Gynecology, Surgical Oncology, Pathology, Cancer Research

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Publish with us